Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · IEX Real-Time Price · USD

51.54

-3.78 (-6.83%)

At close: Jul 2, 2024, 4:00 PM

51.77

+0.23 (0.45%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Viking Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2013
Market Capitalization	5,683	1,862	721	360	411	580	Upgrade
Market Cap Growth	531.10%	158.23%	100.31%	-12.38%	-29.13%	6.02%	Upgrade
Enterprise Value	4,721	1,501	567	158	163	305	Upgrade
PE Ratio	-	-21.67	-10.47	-6.54	-10.40	-22.48	Upgrade
PB Ratio	6.09	5.34	4.96	1.78	1.68	2.09	Upgrade
P/FCF Ratio	-150.18	-25.37	-14.89	-7.56	-18.86	-23.41	Upgrade
P/OCF Ratio	-150.18	-25.37	-14.89	-7.56	-18.86	-23.41	Upgrade
EV/EBITDA Ratio	-77.90	-17.53	-8.27	-2.88	-4.15	-11.93	Upgrade
EV/EBIT Ratio	-77.66	-17.47	-8.23	-2.87	-4.12	-11.81	Upgrade
EV/FCF Ratio	-132.65	-20.45	-11.71	-3.32	-7.47	-12.30	Upgrade
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.00	Upgrade
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	0.00	-0.01	-0.03	Upgrade
Debt / FCF Ratio	-0.02	-0.02	-0.03	0.00	-0.02	-0.03	Upgrade
Quick Ratio	29.38	18.92	7.09	23.03	20.48	40.68	Upgrade
Current Ratio	29.49	19.19	7.61	23.98	21.12	41.83	Upgrade
Return on Equity (ROE)	-18.40%	-27.80%	-42.80%	-25.10%	-15.40%	-9.00%	Upgrade
Return on Assets (ROA)	-17.70%	-26.40%	-38.70%	-23.80%	-14.80%	-8.80%	Upgrade
Return on Capital (ROIC)	-12.23%	-28.83%	-47.90%	-27.58%	-17.43%	-11.77%	Upgrade
Earnings Yield	-1.65%	-4.61%	-9.55%	-15.28%	-9.62%	-4.45%	Upgrade
FCF Yield	-0.97%	-3.94%	-6.71%	-13.22%	-5.30%	-4.27%	Upgrade
Buyback Yield / Dilution	-32.04%	-22.79%	0.47%	-6.34%	-0.89%	-24.97%	Upgrade
Total Shareholder Return	-32.04%	-22.79%	0.47%	-6.34%	-0.89%	-24.97%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).